Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca Arruga

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
European Journal of Medical Genetics|November 6, 2021
A novel COLEC10 mutation in a child with 3MC syndromeMartina Migliorero, Silvia Kalantari, Valeria Bracciamà, et al.
Hematology (Amsterdam, Netherlands)|September 29, 2005
WT1 overexpression: a clinically useful marker in acute and chronic myeloid leukemiasGiuseppe Saglio, Sonia Carturan, Sara Grillo, et al.
Haematologica|April 18, 2020
Targeting of the A2A adenosine receptor counteracts immunosuppression in vivo in a mouse model of chronic lymphocytic leukemiaFrancesca Arruga, Sara Serra, Nicoletta Vitale, et al.
Annals of the New York Academy of Sciences|January 31, 2007
Genetic abnormalities as targets for molecular therapies in myelodysplastic syndromesDaniela Cilloni, Emanuela Messa, Francesca Messa, et al.
Cancer Research|May 9, 2018
Novel Richter Syndrome Xenograft Models to Study Genetic Architecture, Biology, and Therapy ResponsesTiziana Vaisitti, Esteban Braggio, John N Allan, et al.
Acta Haematologica|October 1, 2008
Detection of humoral immune responses against WT1 antigen in patients affected by different hematological malignanciesPaolo Nicoli, Ilaria Defilippi, Sonia Carturan, et al.
Cancers|January 9, 2021
NAMPT Over-Expression Recapitulates the BRAF Inhibitor Resistant Phenotype Plasticity in MelanomaValentina Audrito, Vincenzo Gianluca Messana, Enrico Moiso, et al.
Blood|December 8, 2009
FOXO transcription factor activity is partially retained in quiescent CML stem cells and induced by tyrosine kinase inhibitors in CML progenitor cellsFrancesca Pellicano, Daniela Cilloni, G Vignir Helgason, et al.
Blood|March 31, 2021
Synergistic efficacy of the dual PI3K-δ/γ inhibitor duvelisib with the Bcl-2 inhibitor venetoclax in Richter syndrome PDX modelsAndrea Iannello, Nicoletta Vitale, Silvia Coma, et al.
Haematologica|September 2, 2017
Targeting metabolism and survival in chronic lymphocytic leukemia and Richter syndrome cells by a novel NF-κB inhibitorTiziana Vaisitti, Federica Gaudino, Samedy Ouk, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
European Journal of Medical Genetics|November 6, 2021
A novel COLEC10 mutation in a child with 3MC syndromeMartina Migliorero, Silvia Kalantari, Valeria Bracciamà, et al.
Hematology (Amsterdam, Netherlands)|September 29, 2005
WT1 overexpression: a clinically useful marker in acute and chronic myeloid leukemiasGiuseppe Saglio, Sonia Carturan, Sara Grillo, et al.
Haematologica|April 18, 2020
Targeting of the A2A adenosine receptor counteracts immunosuppression in vivo in a mouse model of chronic lymphocytic leukemiaFrancesca Arruga, Sara Serra, Nicoletta Vitale, et al.
Annals of the New York Academy of Sciences|January 31, 2007
Genetic abnormalities as targets for molecular therapies in myelodysplastic syndromesDaniela Cilloni, Emanuela Messa, Francesca Messa, et al.
Cancer Research|May 9, 2018
Novel Richter Syndrome Xenograft Models to Study Genetic Architecture, Biology, and Therapy ResponsesTiziana Vaisitti, Esteban Braggio, John N Allan, et al.
Acta Haematologica|October 1, 2008
Detection of humoral immune responses against WT1 antigen in patients affected by different hematological malignanciesPaolo Nicoli, Ilaria Defilippi, Sonia Carturan, et al.
Cancers|January 9, 2021
NAMPT Over-Expression Recapitulates the BRAF Inhibitor Resistant Phenotype Plasticity in MelanomaValentina Audrito, Vincenzo Gianluca Messana, Enrico Moiso, et al.
Blood|December 8, 2009
FOXO transcription factor activity is partially retained in quiescent CML stem cells and induced by tyrosine kinase inhibitors in CML progenitor cellsFrancesca Pellicano, Daniela Cilloni, G Vignir Helgason, et al.
Blood|March 31, 2021
Synergistic efficacy of the dual PI3K-δ/γ inhibitor duvelisib with the Bcl-2 inhibitor venetoclax in Richter syndrome PDX modelsAndrea Iannello, Nicoletta Vitale, Silvia Coma, et al.
Haematologica|September 2, 2017
Targeting metabolism and survival in chronic lymphocytic leukemia and Richter syndrome cells by a novel NF-κB inhibitorTiziana Vaisitti, Federica Gaudino, Samedy Ouk, et al.
Pageof 5